This report provides an overview of Neuromyelitis Optica (Devic's Syndrome) Clinical trials scenario. This report provides top line data relating to the clinical trials on Neuromyelitis Optica (Devic's Syndrome) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). the publisher Clinical Trial Reports are generated using the publisher's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Reasons to Buy
Assists in formulating key business strategies with regards to investment
Helps in identifying prominent locations for conducting clinical trials which saves time and cost
Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
Supports understanding of trials count and enrollment trends by country in global therapeutics market
Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
Facilitates clinical trial assessment of the indication on a global, regional and country level
Curator Hotel & Resort Collection ("Curator") is announcing Toast as a new preferred cloud-based point-of-sale (POS) platform partner. This collaboration will help member hotels' F&B outlets improve operations, increase sales, and create an overall...
? The median-priced U.S. luxury home sold for a record $1,225,000 in the first quarter, up 8.7% from a year earlier, according to a new report from Redfin (redfin.com), the technology-powered real estate brokerage. Prices of non-luxury homes rose at...
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company sought an extension of its previously announced stay of proceedings ("Stay") under the Companies' Creditors Arrangement Act (the "CCAA") at a hearing before the Ontario...
Triad Financial Services, a leader in the manufactured home lending industry, is providing trusted financing for homeowners across the U.S. The company has partnered with Praxent, a financial technology consulting and engineering firm, to migrate its...
Shift4 , the leader in integrated payments and commerce technology, will release its first quarter 2024 financial results before market open on Thursday, May 9, 2024. Management will host a live conference call at 8:30 am ET to discuss these results....
The global digital lending market size is estimated to grow by USD 19140.24 mn from 2023 to 2027, according to Technavio. The market is estimated to grow at a CAGR of 19.89% during the forecast period. The digital lending market is experiencing...